Blue Jet Healthcare Limited (BOM:544009)

India · Delayed Price · Currency is INR

605.50

-0.25 (-0.04%)

At close: Jul 14, 2026

-36.61% (1Y)

Market Cap	103.83B -30.1%
Revenue (ttm)	9.47B -8.0%
Net Income	2.48B -18.8%
EPS	14.29 -18.8%
Shares Out	n/a
PE Ratio	41.90
Forward PE	34.72
Dividend	1.20 (0.21%)
Ex-Dividend Date	Sep 19, 2025

Volume	51,997
Open	601.00
Previous Close	605.75
Day's Range	598.95 - 624.40
52-Week Range	325.20 - 1,028.20
Beta	n/a
Analysts	Buy
Price Target	501.00 (-17.26%)
Earnings Date	Jul 30, 2026

About Blue Jet Healthcare

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norw... [Read more]

Industry Pharmaceutical Preparations

Founded 1968

Employees 196

Stock Exchange Bombay Stock Exchange

Ticker Symbol 544009

Full Company Profile

Financial Performance

In fiscal year 2026, Blue Jet Healthcare's revenue was 9.47 billion, a decrease of -8.03% compared to the previous year's 10.30 billion. Earnings were 2.48 billion, a decrease of -18.80%.

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for 544009 stock is "Buy." The 12-month stock price target is ₹501.00, which is a decrease of -17.26% from the latest price.

Price Target

₹501.00

(-17.26% downside)

Analyst Consensus: Buy

Stock Forecasts